Otogenetics

Patients

  • GxVISION® Carrier Screening

  • EnVISION Non Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

Physicians

  • GxVISION® Carrier Screening

  • EnVISION Non-Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

  • GxVISION® Congenital Hearing Loss

Education Center

  • Physician Education Resources

  • Patient Education Resources

  • Patient Stories

Research & Partnerships

  • Research and Research Partners

  • GBinsight

Company

  • About Us

  • Contact Us

Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2

August 6, 2024

Wang H, Lai Y, Mathis BJ, Wang W, Li S, Qu C, Li B, Shao L, Song H, Janicki JS, Sun SC, Wang XL, Tang D, Cui T. (2015) Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2. J Mol Cell Cardio. 84:143-53.

Otogenetics
  • 4553 Winters Chapel Rd., Suite 100 Atlanta, GA 30360
  • +1 (855)-686-4363
Contact Us

Patients

  • GxVISION® Carrier Screening

  • EnVISION Non Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

Physicians

  • GxVISION® Carrier Screening

  • EnVISION Non-Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

  • GxVISION® Congenital Hearing Loss

Education Center

  • Physician Education Resources

  • Patient Education Resources

  • Patient Stories

Research & Partnerships

  • Research and Research Partners

  • GBinsight

Company

  • About Us

  • Contact Us

  • Privacy Policy

© Otogenetics 2025 All Rights Reserved.